| First Author | Mishra I | Year | 2022 |
| Journal | Cell Metab | Volume | 34 |
| Issue | 4 | Pages | 549-563.e8 |
| PubMed ID | 35298903 | Mgi Jnum | J:325708 |
| Mgi Id | MGI:7286148 | Doi | 10.1016/j.cmet.2022.02.012 |
| Citation | Mishra I, et al. (2022) Protein tyrosine phosphatase receptor delta serves as the orexigenic asprosin receptor. Cell Metab 34(4):549-563.e8 |
| abstractText | Asprosin is a fasting-induced glucogenic and centrally acting orexigenic hormone. The olfactory receptor Olfr734 is known to be the hepatic receptor for asprosin that mediates its effects on glucose production, but the receptor for asprosin's orexigenic function has been unclear. Here, we have identified protein tyrosine phosphatase receptor delta (Ptprd) as the orexigenic receptor for asprosin. Asprosin functions as a high-affinity Ptprd ligand in hypothalamic AgRP neurons, regulating the activity of this circuit in a cell-autonomous manner. Genetic ablation of Ptprd results in a strong loss of appetite, leanness, and an inability to respond to the orexigenic effects of asprosin. Ablation of Ptprd specifically in AgRP neurons causes resistance to diet-induced obesity. Introduction of the soluble Ptprd ligand-binding domain in the circulation of mice suppresses appetite and blood glucose levels by sequestering plasma asprosin. Identification of Ptprd as the orexigenic asprosin receptor creates a new avenue for the development of anti-obesity therapeutics. |
